KRT9 Gene Epidermolytic Palmoplantar Keratoderma Genetic Test
Welcome to DNA Labs UAE’s blog on KRT9 Gene Epidermolytic Palmoplantar Keratoderma Genetic Test. In this blog, we will discuss the symptoms, diagnosis, and cost of the test, along with other important details.
Test Details
Epidermolytic palmoplantar keratoderma (EPPK) is a rare genetic disorder characterized by thickened skin on the palms of the hands and soles of the feet. It is caused by mutations in the KRT9 gene, which provides instructions for producing a protein called keratin 9.
Test Name: KRT9 Gene Epidermolytic Palmoplantar Keratoderma Genetic Test
- Components: NGS Technology
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Test Type: Osteology Dermatology Immunology Disorders
- Doctor: Dermatologist
- Test Department: Genetics
- Pre Test Information: Clinical History of Patient who is going for KRT9 Gene Epidermolytic Palmoplantar Keratoderma NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KRT9 Gene Epidermolytic Palmoplantar Keratoderma NGS Genetic DNA Test gene KRT9
Method
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of EPPK, NGS genetic testing can be used to identify mutations in the KRT9 gene, providing a definitive diagnosis for individuals suspected to have the condition.
Test Process
NGS genetic testing for EPPK involves obtaining a DNA sample, typically through a blood sample or cheek swab, from the individual being tested. The DNA is then sequenced using NGS technology, which reads the genetic code and identifies any variations or mutations in the KRT9 gene. The results of the test can help confirm a diagnosis of EPPK and provide information about the specific mutation(s) present.
Benefits of Genetic Testing
Genetic testing for EPPK can be beneficial for individuals with symptoms of the condition, as it can provide a definitive diagnosis and help guide treatment and management options. It can also be useful for family members of individuals with EPPK, as it can determine if they are carriers of the mutation and at risk of passing it on to their children.
Consultation
It is important to consult with a healthcare professional or genetic counselor before undergoing genetic testing to understand the benefits, limitations, and potential implications of the test. They can help determine if NGS genetic testing for EPPK is appropriate and provide guidance on the next steps.
| Test Name | KRT9 Gene Epidermolytic palmoplantar keratoderma Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for KRT9 Gene Epidermolytic palmoplantar keratoderma NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KRT9 Gene Epidermolytic palmoplantar keratoderma NGS Genetic DNA Test gene KRT9 |
| Test Details |
Epidermolytic palmoplantar keratoderma (EPPK) is a rare genetic disorder characterized by thickened skin on the palms of the hands and soles of the feet. It is caused by mutations in the KRT9 gene, which provides instructions for producing a protein called keratin 9. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of EPPK, NGS genetic testing can be used to identify mutations in the KRT9 gene, providing a definitive diagnosis for individuals suspected to have the condition. NGS genetic testing for EPPK involves obtaining a DNA sample, typically through a blood sample or cheek swab, from the individual being tested. The DNA is then sequenced using NGS technology, which reads the genetic code and identifies any variations or mutations in the KRT9 gene. The results of the test can help confirm a diagnosis of EPPK and provide information about the specific mutation(s) present. Genetic testing for EPPK can be beneficial for individuals with symptoms of the condition, as it can provide a definitive diagnosis and help guide treatment and management options. It can also be useful for family members of individuals with EPPK, as it can determine if they are carriers of the mutation and at risk of passing it on to their children. It is important to consult with a healthcare professional or genetic counselor before undergoing genetic testing to understand the benefits, limitations, and potential implications of the test. They can help determine if NGS genetic testing for EPPK is appropriate and provide guidance on the next steps. |
